Core Insights - Techne (TECH) reported revenue of $286.56 million for the quarter ended September 2025, reflecting a year-over-year decline of 1% and a surprise of -0.96% compared to the Zacks Consensus Estimate of $289.34 million [1] - The earnings per share (EPS) for the same period was $0.42, unchanged from the previous year, indicating no EPS surprise against the consensus estimate [1] Financial Performance Metrics - Organic growth was reported at -1%, contrasting with the estimated growth of 1.1% by analysts [4] - Net Sales in Protein Sciences amounted to $202.2 million, below the average estimate of $208.25 million, representing a year-over-year decline of -1.1% [4] - Net Sales in Diagnostics and Spatial Biology reached $79.5 million, slightly below the average estimate of $80.65 million, showing a year-over-year change of -4.4% [4] Stock Performance - Techne's shares have returned +3.2% over the past month, outperforming the Zacks S&P 500 composite, which saw a +1% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]
Here's What Key Metrics Tell Us About Techne (TECH) Q1 Earnings